During the past decade, Azienda Ospedaliera di Cosenza conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera di Cosenza" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 2 trials, followed by "Axon srl" with 1 trials sponsored, "Azienda Ospedaliera Cosenza" with 1 trials sponsored, "Consorzio Oncotech" with 1 trials sponsored and "IRCCS San Raffaele" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera di Cosenza" #1 collaborator was "Arcispedale Santa Maria Nuova-IRCCS" with 1 trials as a collaborator, "Azienda Ospedaliero-Universitaria di Parma" with 1 trials as a collaborator, "Centro di Riferimento Oncologico - Aviano" with 1 trials as a collaborator, "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano" with 1 trials as a collaborator and "IRCCS Sacro Cuore Don Calabria di Negrar" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera di Cosenza" are "AAA - Abdominal Aortic Aneurysm" (1 trials), "Aneurysm" (1 trials), "Cancer" (1 trials), "Chemotherapy-induced Nausea and Vomiting" (1 trials) and "Lymphoma, B-Cell" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera di Cosenza" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera di Cosenza" are "Device" (3 trials), "Drug" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aldesleukin" (1 trials), "Busulfan" (1 trials), "CHOP" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera di Cosenza" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera di Cosenza". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Azienda Ospedaliera di Cosenza, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera di Cosenza, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Azienda Ospedaliera di Cosenza has several departments that took part in Clinical trials: "U.O. Ematologia - P.O. Annunziata - A.O. di Cosenza" - 15 trials, "Ospedale Annunziata - Uoc Cardiologia" - 4 trials, "Azienda Ospedaliera di Cosenza - UOC Ematologia" - 3 trials, "Ospedale Mariano Santo, U.O. di Oncologia Medica" - 3 trials